NO20083033L - Anvendelse av benzofuserte heterocykliske sulfamidderivater som neurobeskyttende midler - Google Patents
Anvendelse av benzofuserte heterocykliske sulfamidderivater som neurobeskyttende midlerInfo
- Publication number
- NO20083033L NO20083033L NO20083033A NO20083033A NO20083033L NO 20083033 L NO20083033 L NO 20083033L NO 20083033 A NO20083033 A NO 20083033A NO 20083033 A NO20083033 A NO 20083033A NO 20083033 L NO20083033 L NO 20083033L
- Authority
- NO
- Norway
- Prior art keywords
- sulfamide derivatives
- neuroprotective agents
- treating
- formula
- benzofused heterocyclic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75149405P | 2005-12-19 | 2005-12-19 | |
US11/612,146 US20070155823A1 (en) | 2005-12-19 | 2006-12-18 | Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents |
PCT/US2006/048451 WO2007075698A2 (en) | 2005-12-19 | 2006-12-19 | Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20083033L true NO20083033L (no) | 2008-09-16 |
Family
ID=37951698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20083033A NO20083033L (no) | 2005-12-19 | 2008-07-04 | Anvendelse av benzofuserte heterocykliske sulfamidderivater som neurobeskyttende midler |
Country Status (24)
Country | Link |
---|---|
US (1) | US20070155823A1 (sl) |
EP (1) | EP1968571B1 (sl) |
JP (1) | JP5190373B2 (sl) |
KR (1) | KR20080089405A (sl) |
AT (1) | ATE536182T1 (sl) |
AU (1) | AU2006331783A1 (sl) |
BR (1) | BRPI0620060A2 (sl) |
CA (1) | CA2634088A1 (sl) |
CR (1) | CR10171A (sl) |
CY (1) | CY1112444T1 (sl) |
DK (1) | DK1968571T3 (sl) |
EA (1) | EA016628B1 (sl) |
ES (1) | ES2375845T3 (sl) |
HK (1) | HK1124544A1 (sl) |
HR (1) | HRP20120018T1 (sl) |
IL (1) | IL192106A0 (sl) |
MY (1) | MY149175A (sl) |
NO (1) | NO20083033L (sl) |
NZ (1) | NZ569041A (sl) |
PL (1) | PL1968571T3 (sl) |
PT (1) | PT1968571E (sl) |
RS (1) | RS52220B (sl) |
SI (1) | SI1968571T1 (sl) |
WO (1) | WO2007075698A2 (sl) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
CN101754947A (zh) * | 2005-05-20 | 2010-06-23 | 詹森药业有限公司 | 磺酰胺衍生物的制备方法 |
US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
TW200812573A (en) * | 2006-05-19 | 2008-03-16 | Janssen Pharmaceutica Nv | Co-therapy for the treatment of epilepsy and related disorders |
US20090247616A1 (en) * | 2008-03-26 | 2009-10-01 | Smith-Swintosky Virginia L | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety |
US20090247617A1 (en) * | 2008-03-26 | 2009-10-01 | Abdel-Magid Ahmed F | Process for the preparation of benzo-fused heteroaryl sulfamates |
CA2722986A1 (en) * | 2008-04-29 | 2009-11-05 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Modulators of dopamine neurotransmission |
CA2722978A1 (en) * | 2008-04-29 | 2009-11-05 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Modulators of dopamine neurotransmission |
EP2271635A1 (en) * | 2008-04-29 | 2011-01-12 | NSAB, Filial af NeuroSearch Sweden AB, Sverige | Modulators of dopamine neurotransmission |
EA018567B1 (ru) | 2008-06-23 | 2013-08-30 | Янссен Фармацевтика Нв | Кристаллическая форма (2s)-(-)-n-(6-хлор-2,3-дигидробензо[1,4]диоксин-2-илметил)сульфамида |
TWI406596B (zh) | 2008-06-30 | 2013-08-21 | Green Solution Tech Co Ltd | 發光二極體驅動電路、發光二極體驅動控制單元及其電晶體開關模組 |
US8815939B2 (en) * | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
JP2014528399A (ja) | 2011-09-29 | 2014-10-27 | ヤンセン ファーマシューティカ エヌ.ベー. | スルファミド誘導体の改善された調製プロセス |
CA2850513A1 (en) | 2011-09-29 | 2013-04-04 | Janssen Pharmaceutica Nv | Process for the preparation of sulfamide derivatives |
SI2865663T1 (sl) * | 2012-06-21 | 2017-07-31 | Eisai R&D Management Co., Ltd. | Novi derivati indansulfamida |
SG11202007200YA (en) | 2018-03-20 | 2020-08-28 | Eisai R&D Man Co Ltd | Epilepsy treatment agent |
Family Cites Families (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2527861A (en) * | 1948-05-07 | 1950-10-31 | Monsanto Chemicals | Mono alkyl sulfamides |
BE636655A (sl) * | 1962-09-14 | |||
US3318952A (en) * | 1964-01-22 | 1967-05-09 | Sandoz Ag | Dibenzylsulfamides |
US3383414A (en) * | 1964-08-26 | 1968-05-14 | Sandoz Ag | Benzocycloalkyl sulfamides |
US3539573A (en) * | 1967-03-22 | 1970-11-10 | Jean Schmutz | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
US3621096A (en) * | 1969-04-03 | 1971-11-16 | Univ North Carolina | Antidepressant method and composition for same comprising a tricyclic antidepressant and a thyroid hormone |
US5212326A (en) * | 1979-08-20 | 1993-05-18 | Abbott Laboratories | Sodium hydrogen divalproate oligomer |
FR2479825A1 (fr) * | 1980-04-04 | 1981-10-09 | Fabre Sa Pierre | Benzodioxanne 1,4 methoxy-2 propanolamines, leur preparation et leur application en tant que medicaments |
US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
GB8607684D0 (en) * | 1986-03-27 | 1986-04-30 | Ici America Inc | Thiazepine compounds |
US4831031A (en) * | 1988-01-22 | 1989-05-16 | Pfizer Inc. | Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity |
US5158952A (en) * | 1988-11-07 | 1992-10-27 | Janssen Pharmaceutica N.V. | 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use |
GB8908085D0 (en) * | 1989-04-11 | 1989-05-24 | Lundbeck & Co As H | New therapeutic use |
US5238945A (en) * | 1989-04-11 | 1993-08-24 | H. Lundbeck A/S | Method of treating psychoses |
US5194446A (en) * | 1989-06-12 | 1993-03-16 | A. H. Robins Company, Incorporated | Compounds having one or more aminosulfaonyloxy radicals useful as pharmaceuticals |
US5273993A (en) * | 1989-06-12 | 1993-12-28 | A. H. Robins Company, Incorporated | Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals |
US5192785A (en) * | 1989-09-03 | 1993-03-09 | A. H. Robins Company, Incorporated | Sulfamates as antiglaucoma agents |
US5229382A (en) * | 1990-04-25 | 1993-07-20 | Lilly Industries Limited | 2-methyl-thieno-benzodiazepine |
IL103172A (en) * | 1991-09-19 | 1997-01-10 | Mcneilab Inc | Preparation of chlorosulfate and sulfamate derivatives of 2, 3:4, 5-bis-o-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl) methanol |
US5242942A (en) * | 1992-04-28 | 1993-09-07 | Mcneilab, Inc. | Anticonvulsant fructopyranose cyclic sulfites and sulfates |
US5258402A (en) * | 1992-06-11 | 1993-11-02 | Mcneil-Ppc, Inc. | Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates |
US5312925A (en) * | 1992-09-01 | 1994-05-17 | Pfizer Inc. | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride |
US5384327A (en) * | 1992-12-22 | 1995-01-24 | Mcneilab, Inc. | Anticonvulsant sorbopyranose sulfamates |
US5731348A (en) * | 1995-02-15 | 1998-03-24 | Bearsden Bio, Inc. | Alkylcarboxy amino acids-modulators of the kainate receptor |
JP3235448B2 (ja) * | 1995-03-24 | 2001-12-04 | ダイソー株式会社 | 1,4−ベンゾジオキサン誘導体の製法 |
US5998380A (en) * | 1995-10-13 | 1999-12-07 | New England Medical Center Hospitals, Inc. | Treatment of migraine |
WO1997019682A1 (en) * | 1995-12-01 | 1997-06-05 | Synaptic Pharmaceutical Corporation | Aryl sulfonamide and sulfamide derivatives and uses thereof |
US5753694A (en) * | 1996-06-28 | 1998-05-19 | Ortho Pharmaceutical Corporation | Anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (ALS) |
US5753693A (en) * | 1996-06-28 | 1998-05-19 | Ortho Pharmaceutical Corporation | Anticonvulsant derivatives useful in treating manic-depressive bipolar disorder |
EP0915697B1 (en) * | 1996-06-28 | 2002-09-18 | Ortho-McNeil Pharmaceutical, Inc. | Anticonvulsant sulfamate derivatives useful in treating obesity |
CA2264182A1 (en) * | 1996-08-23 | 1998-02-26 | Algos Pharmaceutical Corporation | Anticonvulsant containing composition for treating neuropathic pain |
US20020015713A1 (en) * | 1996-10-24 | 2002-02-07 | Murdock Robert W. | Methods and transdermal compositions for pain relief |
US5760007A (en) * | 1997-07-16 | 1998-06-02 | Ortho Pharmaceutical Corporation | Anticonvulsant derivatives useful in treating neuropathic pain |
US5935933A (en) * | 1997-07-16 | 1999-08-10 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivatives useful in treating neuropathic pain |
EP1014959B1 (en) * | 1997-08-15 | 2004-10-20 | Carolyn Ann Fairbanks | Agmatine as a treatment for neuropathic pain |
BR0008176A (pt) * | 1999-01-19 | 2001-11-06 | Ortho Mcneil Pharm Inc | Derivados anti-convulsivantes úteis no tratamento de cefaléias em cacho |
KR100697485B1 (ko) * | 1999-02-24 | 2007-03-20 | 유니버시티 오브 신시내티 | 충동 자제 이상 치료를 위한 설파메이트 유도체의 용도 |
CA2369093C (en) * | 1999-04-08 | 2005-10-18 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivatives useful in lowering lipids |
WO2000061138A1 (en) * | 1999-04-08 | 2000-10-19 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders |
IL148019A0 (en) * | 1999-08-20 | 2002-09-12 | Ortho Mcneil Pharm Inc | Composition comprising a tramadol material and an anticonvulsant drug |
US6322503B1 (en) * | 2000-02-17 | 2001-11-27 | G. Roger Sparhawk, Jr. | Method of diagnosing, tracking, and treating depression |
WO2002003984A2 (en) * | 2000-07-07 | 2002-01-17 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivatives useful for treating and preventing the development of type ii diabetes mellitus and syndrome x |
AU2001280865A1 (en) * | 2000-08-02 | 2002-02-13 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivatives useful for the treatment of depression |
US7256184B2 (en) * | 2000-10-16 | 2007-08-14 | Rodriguez Victorio C | Treatment of aging disorders in humans |
CA2434491A1 (en) * | 2001-01-30 | 2002-08-08 | Merck & Co., Inc. | Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
US20030100594A1 (en) * | 2001-08-10 | 2003-05-29 | Pharmacia Corporation | Carbonic anhydrase inhibitor |
US6559293B1 (en) * | 2002-02-15 | 2003-05-06 | Transform Pharmaceuticals, Inc. | Topiramate sodium trihydrate |
US8637512B2 (en) * | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
US6949518B1 (en) * | 2003-06-25 | 2005-09-27 | Pao-Hsien Chu | Methods for treating macular degeneration with topiramate |
CN1897950A (zh) * | 2003-10-14 | 2007-01-17 | 惠氏公司 | 稠合芳基和杂芳基衍生物及其使用方法 |
AR049646A1 (es) * | 2004-06-16 | 2006-08-23 | Janssen Pharmaceutica Nv | Derivados de sulfamato y sulfamida utiles para el tratamiento de la epilepsia y trastornos relacionados |
WO2006023861A1 (en) * | 2004-08-24 | 2006-03-02 | Janssen Pharmaceutica N.V. | Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents |
US20060276528A1 (en) * | 2004-08-24 | 2006-12-07 | Abdel-Magid Ahmed F | Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents |
JP2008538575A (ja) * | 2005-04-22 | 2008-10-30 | ワイス | ベンゾジオキサンおよびベンゾジオキソラン誘導体ならびにそれらの使用 |
CN101754947A (zh) * | 2005-05-20 | 2010-06-23 | 詹森药业有限公司 | 磺酰胺衍生物的制备方法 |
US20070155824A1 (en) * | 2005-12-19 | 2007-07-05 | Smith-Swintosky Virginia L | Use of benzo-fused heterocycle sulfamide derivatives for disease modification / epileptogenesis |
TW200812573A (en) * | 2006-05-19 | 2008-03-16 | Janssen Pharmaceutica Nv | Co-therapy for the treatment of epilepsy and related disorders |
US20070293476A1 (en) * | 2006-05-19 | 2007-12-20 | Smith-Swintosky Virginia L | Co-therapy for the treatment of epilepsy and related disorders |
MX2010007490A (es) * | 2008-01-07 | 2010-08-17 | Janssen Pharmaceutica Nv | Preparacion de derivados de sulfamida. |
US20090247617A1 (en) * | 2008-03-26 | 2009-10-01 | Abdel-Magid Ahmed F | Process for the preparation of benzo-fused heteroaryl sulfamates |
US20090247618A1 (en) * | 2008-03-26 | 2009-10-01 | Ballentine Scott A | Process for preparation of benzo-fused heteroaryl derivatives |
EA018567B1 (ru) * | 2008-06-23 | 2013-08-30 | Янссен Фармацевтика Нв | Кристаллическая форма (2s)-(-)-n-(6-хлор-2,3-дигидробензо[1,4]диоксин-2-илметил)сульфамида |
US8815939B2 (en) * | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
-
2006
- 2006-12-18 US US11/612,146 patent/US20070155823A1/en not_active Abandoned
- 2006-12-19 ES ES06845823T patent/ES2375845T3/es active Active
- 2006-12-19 EA EA200870087A patent/EA016628B1/ru not_active IP Right Cessation
- 2006-12-19 PL PL06845823T patent/PL1968571T3/pl unknown
- 2006-12-19 AU AU2006331783A patent/AU2006331783A1/en not_active Abandoned
- 2006-12-19 PT PT06845823T patent/PT1968571E/pt unknown
- 2006-12-19 CA CA002634088A patent/CA2634088A1/en not_active Abandoned
- 2006-12-19 RS RS20120057A patent/RS52220B/en unknown
- 2006-12-19 JP JP2008547445A patent/JP5190373B2/ja not_active Expired - Fee Related
- 2006-12-19 DK DK06845823.1T patent/DK1968571T3/da active
- 2006-12-19 NZ NZ569041A patent/NZ569041A/en not_active IP Right Cessation
- 2006-12-19 BR BRPI0620060-5A patent/BRPI0620060A2/pt not_active IP Right Cessation
- 2006-12-19 MY MYPI20082184A patent/MY149175A/en unknown
- 2006-12-19 WO PCT/US2006/048451 patent/WO2007075698A2/en active Application Filing
- 2006-12-19 EP EP06845823A patent/EP1968571B1/en active Active
- 2006-12-19 SI SI200631254T patent/SI1968571T1/sl unknown
- 2006-12-19 KR KR1020087017501A patent/KR20080089405A/ko not_active Application Discontinuation
- 2006-12-19 AT AT06845823T patent/ATE536182T1/de active
-
2008
- 2008-06-12 IL IL192106A patent/IL192106A0/en unknown
- 2008-07-04 NO NO20083033A patent/NO20083033L/no not_active Application Discontinuation
- 2008-07-21 CR CR10171A patent/CR10171A/es not_active Application Discontinuation
-
2009
- 2009-03-17 HK HK09102533.1A patent/HK1124544A1/xx not_active IP Right Cessation
-
2012
- 2012-01-09 HR HR20120018T patent/HRP20120018T1/hr unknown
- 2012-02-23 CY CY20121100189T patent/CY1112444T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP5190373B2 (ja) | 2013-04-24 |
NZ569041A (en) | 2011-04-29 |
BRPI0620060A2 (pt) | 2011-11-01 |
PT1968571E (pt) | 2012-02-01 |
RS52220B (en) | 2012-10-31 |
ATE536182T1 (de) | 2011-12-15 |
EA016628B1 (ru) | 2012-06-29 |
CY1112444T1 (el) | 2015-12-09 |
US20070155823A1 (en) | 2007-07-05 |
SI1968571T1 (sl) | 2012-03-30 |
IL192106A0 (en) | 2009-08-03 |
EP1968571B1 (en) | 2011-12-07 |
JP2009520031A (ja) | 2009-05-21 |
AU2006331783A1 (en) | 2007-07-05 |
ES2375845T3 (es) | 2012-03-06 |
PL1968571T3 (pl) | 2012-04-30 |
MY149175A (en) | 2013-07-31 |
HRP20120018T1 (hr) | 2012-01-31 |
CA2634088A1 (en) | 2007-07-05 |
EP1968571A2 (en) | 2008-09-17 |
KR20080089405A (ko) | 2008-10-06 |
CR10171A (es) | 2009-01-16 |
EA200870087A1 (ru) | 2009-12-30 |
WO2007075698A3 (en) | 2007-08-16 |
DK1968571T3 (da) | 2012-02-27 |
HK1124544A1 (en) | 2009-07-17 |
WO2007075698A2 (en) | 2007-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20083033L (no) | Anvendelse av benzofuserte heterocykliske sulfamidderivater som neurobeskyttende midler | |
NO20083032L (no) | Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av mani og bipolar forstyrrelse | |
WO2007095618A3 (en) | Benzo-fused heterocycle sulfamide derivatives for the treatment of migraine | |
WO2007095613A3 (en) | Use of benzo-heteroaryl sulfamide derivatives as neuroprotective agents | |
NO20083004L (no) | Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av stoffmisbrukavhengighet | |
DE602006010442D1 (de) | Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von schmerzen | |
MY145823A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity | |
EA200802223A1 (ru) | 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90 | |
MY148459A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression | |
BRPI0921692A2 (pt) | composto carbamato ou o sal do mesmo | |
NO20082214L (no) | 1,1-Diokso-tiomorfolinyl-indolyl-metanonderivater for anvendelse som H3-modulatorer | |
DE602007011434D1 (de) | 1h-indol-5-ylpiperazin-1-ylmethanonderivate | |
WO2007095611A3 (en) | Use of benzo-fused heteroaryl sulfamide derivatives for the treatment of migraine | |
WO2007095609A3 (en) | Use of benzo-heteroaryl sulfamide derivatives for the treatment of mania and bipolar disorder | |
UA96747C2 (ru) | Применение бензоконденсированных гетероциклических сульфамидных производных как нейропротективных агентов | |
WO2010132547A3 (en) | Oxaza heterocyclic compounds for phototherapy | |
UA95094C2 (ru) | Применение бензоконденсированных гетероциклических сульфамидных производных для лечения маниакального синдрома и биполярного расстройства | |
ATE502947T1 (de) | 4,5,6,7-tetrahydrothienoä3,2-cüpyridinderivate als h3-modulatoren | |
TH94294A (th) | การใช้อนุพันธ์เบนโซ-ฟิวเซด เฮเทอโรไซเคิล ซัลฟาไมด์ เป็นสารป้องกันการทำลายเซลล์ประสาทในสมอง | |
UY30157A1 (es) | Uso de derivados de benzo-heteroaril sulfamida como agentes neuroprotectores | |
TH92470B (th) | สารประกอบชนิดใหม่สำหรับการรักษาความผิดปกติทางประสาทวิทยา, จิตเวช หรืออาการปวด | |
UA97106C2 (ru) | Применение производных бензоконденсированного гетероциклического сульфамида для лечения злоупотребления психоактивным веществом и аддикции |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |